Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study

Abstract

Our results do not generally support a carcinogenic effect of r-hGH, but the unexplained trend in cancer mortality risk in relation to GH dose in patients with previous cancer, and the indication of possible effects on bone cancer, bladder cancer, and HL risks, need further investigation.